乙肝肝硬化患者接受治疗期间肿瘤标志物变化的临床意义探讨

Clinical Significance of Changes in Tumor Markers during Treatment of Patients with Hepatitis B Cirrhosis

目的:探究肿瘤标志物变化水平在乙肝肝硬化患者接受治疗期间的临床意义。方法:研究时段为2014年12月至2017年12月,取本院收治的62例乙肝肝硬化患者及来本院进行体检的健康受检者62例,前者为试验组、后者为对照组,试验组实施相应的治疗,分析对照组肿瘤标志物水平与试验组治疗前后肿瘤标志物水平。结果:试验组治疗前肿瘤标志物水平高于治疗后(P<0.05);试验组治疗后肿瘤标志物水平相较于对照组,差异不明显(P>0.05)。结论:在乙肝肝硬化患者接受治疗期间检测肿瘤标志物变化水平,可为临床诊治提供有效的参考依据,值得临床借鉴。

Objective: To explore the clinical significance of tumor marker changes in patients with hepatitis B cirrhosis during treatment. Methods: The study period was from December 2014 to December 2017. 62 patients with hepatitis B cirrhosis admitted to our hospital and 62 healthy subjects who came to our hospital for physical examination were the former. The former was the experimental group and the latter was the control group. The experimental group was treated accordingly, and the tumor marker levels in the control group and the tumor marker levels before and after treatment in the experimental group were analyzed. Results: The tumor marker levels in the experimental group before treatment were higher than those after treatment ( P <0.05). The tumor marker levels in the experimental group were not significantly different from those in the control group ( P >0.05). Conclusion: The detection of tumor marker changes during the treatment of patients with hepatitis B cirrhosis can provide an effective reference for clinical diagnosis and treatment, which is worthy of clinical reference.